Key facts
- This page summarizes Gregory H. Bailey's Form 4 filing for Serina Therapeutics, Inc. (SER).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 20 Sep 2024, 18:59.
Gregory H. Bailey - 18 Sep 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)
- Reporting relationship
- Director
- Issuer ticker
- SER
- Reported as of
- 18 Sep 2024
- Net transaction value
- +$88,257
- SEC form
- 4
- Accepted by SEC
- 20 Sep 2024, 18:59:29 UTC
- Prior SEC filing
- 22 Aug 2024
- Next SEC filing
- 24 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Steve Ledger, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gregory H. Bailey filed Form 4 for Serina Therapeutics, Inc. (SER) on 20 Sep 2024.
Change
- Previous filing in this sequence was filed on 22 Aug 2024.
- Current net transaction value: +$88,257.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SER
transaction
Common Stock
Purchase
- Transaction value
- $16,873
- Shares
- +2,709
- Change %
- +5.7%
- Price
- $6.23
- Shares after
- 50,561
- Date
- 18 Sep 2024
- Ownership
- Direct
- Footnotes
- F1
SER
transaction
Common Stock
Purchase
- Transaction value
- $71,384
- Shares
- +11,679
- Change %
- +23%
- Price
- $6.11
- Shares after
- 62,240
- Date
- 19 Sep 2024
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The price reflects the weighted average purchase price of multiple transactions ranging from a low of $6.18 per share to a high of $6.25 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
Footnote F2
The price reflects the weighted average purchase price of multiple transactions ranging from a low of $5.96 per share to a high of $6.25 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.